211 related articles for article (PubMed ID: 356233)
1. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
Jakobsen A; Sødal G; Flatmark A; Thorsby E
Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
Jakobsen J; Flatmark A; Sodal G; Thorsby E
Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen.
Groth CG; Berg B; Collste H; Lundgren G; Magnusson G; Ringdén O; Pieper R
Scand J Urol Nephrol Suppl; 1977; (42):83-5. PubMed ID: 356230
[TBL] [Abstract][Full Text] [Related]
5. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
Sansom JR; Barnes AD; Hall CL
Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial with AHLG Behring: lack of effect on cadaveric renal graft survival.
Jakobsen A; Flatmark A; Lundgren G; Solheim B; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():205-12. PubMed ID: 6755682
[TBL] [Abstract][Full Text] [Related]
7. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
Taylor HE; Ackman CF; Horowitz I
Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
9. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
10. Antilymphocyte globulin and renal transplantation.
Tagnon A
Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
[TBL] [Abstract][Full Text] [Related]
12. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
13. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
[TBL] [Abstract][Full Text] [Related]
14. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
15. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
16. An analysis of predictors of long-term cadaveric renal allograft survival.
Cole E; Naimark D; Aprile M; Wade J; Cattran D; Pei Y; Fenton S; Robinette M; Zaltsman J; Bear R
Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
[TBL] [Abstract][Full Text] [Related]
17. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
18. Experience with antilymphocyte globulin in 144 renal transplant recipients.
Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
20. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
